title: Prolactin Inhibits BCL6 Expression in Breast Cancer Cells through a MicroRNA-339-5p-Dependent Pathway.
abstract: OBJECTIVE
  Prolactin (PRL) plays a critical role in breast cancer progression by activating its cognate receptor and promotes the growth and differentiation of breast cancer cells. Studies have shown that B-cell lymphoma 6 (BCL6) is the target gene of microRNA-339-5p (miR-339-5p) and that BCL6 expression contributes to breast cancer progression. Herein, we identified PRL as a potent suppressor of BCL6 expression in human breast cancer cells.
  
  
  METHODS
  Western blotting and quantitative reverse transcription-polymerase chain reaction were used to investigate molecular mechanisms underlying miR-339-5p expression and BCL6 manipulation in MCF-7, T47D, and SKBR3 breast cancer cells. Phenotypic changes in these breast cancer cell lines were assessed by performing cell viability (MTT), colony formation, migration, and invasion assays.
  
  
  RESULTS
  PRL suppressed BCL6 protein and mRNA expression and upregulated miR-339-5p expression in MCF-7 and T47D breast cancer cells. Selective downregulation of miR-339-5p expression significantly reversed PRL-induced suppression of BCL6 mRNA and protein expression. Exogenous PRL stimulation significantly decreased the proliferation, colony formation, migration, and invasion of breast cancer cells, and suppression of miR-339-5p expression reversed these processes in vitro.
  
  
  CONCLUSIONS
  These results indicated that PRL inhibited BCL6 expression and regulated breast cancer progression through a miR-339-5p-dependent pathway.
authors.affiliation: Department of Pathology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
authors.forename: Hong
authors.initials: H
authors.lastname: Yan
authors.affiliation: Department of Pathology, The Second People's Hospital of Hefei, Hefei, China.
authors.forename: Min
authors.initials: M
authors.lastname: Zhao
authors.affiliation: Department of Pathology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.; Department of Pathology, Anhui Medical University, Hefei, China.
authors.forename: Shan
authors.initials: S
authors.lastname: Huang
authors.affiliation: Department of Pathology, Anhui Medical University, Hefei, China.
authors.forename: Ping
authors.initials: P
authors.lastname: Chen
authors.affiliation: Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
authors.forename: Wen-Yong
authors.initials: WY
authors.lastname: Wu
authors.affiliation: Department of Pathology, The Second People's Hospital of Hefei, Hefei, China.
authors.forename: Jin
authors.initials: J
authors.lastname: Huang
authors.affiliation: Department of Pathology, Anhui Medical University, Hefei, China.
authors.forename: Zheng-Sheng
authors.initials: ZS
authors.lastname: Wu
authors.affiliation: Department of Pathology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.; Department of Pathology, Anhui Medical University, Hefei, China.
authors.forename: Qiang
authors.initials: Q
authors.lastname: Wu
keywords: B-cell lymphoma 6 proteins; Breast neoplasms; MicroRNA-339-5p; Prolactin